Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment
You're right the FDA decides those categories. But Biogen is the one that created the compound and is pitching it as a drug, when they could've sold it as a nutritional supplement. Why exactly do you think they did that?
There are no comments on this comment yet.
You're right the FDA decides those categories. But Biogen is the one that created the compound and is pitching it as a drug, when they could've sold it as a nutritional supplement. Why exactly do you think they did that?